Title: Innovations in Prostate Cancer Diagnostics by Daphne Hessels
Introduction
Daphne Hessels is a notable inventor in the field of medical diagnostics, particularly focusing on prostate cancer. Her work has contributed significantly to the development of innovative methods for diagnosing and prognosing prostate cancer, which is crucial for improving patient outcomes.
Latest Patents
Daphne Hessels holds two significant patents related to prostate cancer diagnostics. The first patent, titled "Combinations Of Molecular Markers In Prostate Cancer Providing A Diagnostic Tool With Improved Sensitivity/specificity," describes methods for diagnosing high-grade or low-grade prostate cancer using expression level analysis of molecular markers such as DLX1, HOXC6, and HOXD10. This invention aims to enhance the sensitivity and specificity of prostate cancer diagnostics through the analysis of easily obtainable samples like urine or prostatic fluid.
The second patent, "Mrna Ratios In Urinary Sediments And/or Urine As A Prognostic And/or Theranostic Marker For Prostate Cancer," outlines methods and kits for assessing the prognosis of prostate cancer. This method involves determining the ratio of PCA3 and PSA expression in urine samples, correlating this ratio with the aggressiveness and mortality risk of prostate cancer. The invention provides a valuable tool for clinicians to evaluate the risk of mortality in patients based on specific biomarker ratios.
Career Highlights
Daphne Hessels is currently associated with MDxHealth Research B.V., where she continues to innovate in the field of cancer diagnostics. Her contributions have been instrumental in advancing the understanding and detection of prostate cancer, making her a key figure in medical research.
Collaborations
Daphne has collaborated with notable colleagues, including Franciscus Petrus Smit and Jack A Schalken. These collaborations have further enriched her research and development efforts in the field of prostate cancer diagnostics.
Conclusion
Daphne Hessels is a pioneering inventor whose work in prostate cancer diagnostics has the potential to significantly improve patient care. Her innovative approaches and patented technologies are vital in the ongoing fight against prostate cancer.